 - Consolidation therapy: Beginning 4 weeks after completion of induction therapy, patients receive arsenic trioxide and ascorbic acid as in induction therapy; oral dexamethasone on days 1-4, 29-32, and 57-60 weeks 1, 5, and 9; and oral thalidomide once daily in weeks 1-12. 